KARACHI: The Ministry of National Health Services, Regulations and Coordination has appointed Dr. Syed Murtaza Haider Jafry as the new Director of Border Health Services Pakistan (BHS-P), amid an ongoing investigation by the Federal Investigation Agency (FIA) into alleged multibillion-rupee irregularities in vaccine procurement and pricing.
According to an official notification issued on October 26, Dr. Jafry, a BS-19 officer serving as Director at the National Institute of Rehabilitation Medicine (NIRM), has been transferred and posted as Director of Border Health Services Pakistan with immediate effect and until further orders.
The notification, issued with the approval of the Federal Health Secretary, was signed by Section Officer Muhammad Ishaq.
The administrative change comes days after the FIA arrested senior officials associated with Border Health Services Pakistan in connection with an alleged vaccine procurement and pricing scandal involving vaccines intended for Hajj and Umrah pilgrims.
Among those reportedly arrested were former and serving senior officials, including Dr. Abid Hussain Shah, Dr. Pardeep Kumar and Dr. Syed Ghulam Murtaza Shah. An Islamabad court granted the FIA seven-day physical remand of the three suspects on October 21 for further investigation.
According to details reported from the investigation, the case involves a five-year agreement for the supply of meningitis and influenza vaccines to international travellers.
Investigators reportedly questioned a vaccine package priced at Rs. 3,475 against a stated combined retail price of Rs. 2,660, raising concerns over alleged overcharging and procurement irregularities.
The potential financial implications over the five-year period have been estimated at approximately Rs. 2.445 billion. However, this figure remains an investigative estimate and should not be treated as a judicially established financial loss.
The controversy has also prompted federal-level scrutiny, with Prime Minister Shehbaz Sharif reportedly ordering a high-level inquiry, while the Ministry of National Health Services initiated a separate review of vaccine pricing and procurement procedures.
The investigation has raised serious questions about financial transparency, procurement oversight, vaccine pricing mechanisms and accountability within Border Health Services Pakistan, an institution responsible for important public health functions at international entry and exit points.
Reports of disruptions to vaccination services for international travellers have further highlighted concerns about the potential impact of the controversy on passengers, particularly Hajj and Umrah pilgrims requiring mandatory vaccination and related certification.
The appointment of Dr. Jafry is expected to place renewed attention on administrative oversight, operational continuity and public confidence in the institution.
However, the ministry's notification does not specify the reason for the transfer or explicitly link the appointment to the ongoing FIA investigation.
Several important questions remain unanswered: Will the new administration conduct a comprehensive audit of vaccine procurement contracts and payments collected from travellers? Will the authorities review vaccination certificate issuance, financial records and pricing approvals? And will any financial losses established through investigation be recovered from those found responsible?
The federal government also faces the challenge of ensuring uninterrupted vaccination services, transparent procurement practices and effective regulatory supervision while the investigation continues.
The allegations against the arrested officials remain subject to investigation and judicial proceedings, and no final determination of criminal liability has been established.
Health Matters Media will continue following developments in the vaccine procurement investigation, administrative accountability and reforms within Border Health Services Pakistan, particularly their implications for public health and international travellers.
